Key Highlights
- Merion, formerly known as E-World USA Holding, Inc., sells dietary supplements and personal-care products across the U.S. and China.
- Recent annual Revenue has run only in the low hundreds of thousands of dollars, alongside reported net losses.
- The company's market Capitalization sits in the low thousands of dollars, with shares outstanding numbering in the tens of millions.
- No verified transformational announcement, such as an acquisition, financing, or major product launch, has been confirmed.
Few tickers embody the quiet limbo of the deep over-the-counter market like EWLU. Merion, Inc (OTC:EWLU), a small health and nutritional-supplements company with roots in both China and the United States, trades at a fraction of a cent and has barely registered a pulse in recent sessions.
Company and Latest Development
Merion, Inc, formerly known as E-World USA Holding, Inc., the origin of its EWLU ticker, sells dietary supplements and personal-care products, including formulations marketed for heart and liver health and a grey-coverage hair product. The company operates across the U.S. and China and remains a genuinely tiny operation, reporting only a handful of employees.
No verified transformational announcement, no acquisition, financing or major product launch, has been confirmed that would explain a change in the shares. The most recent developments visible are routine periodic filings with the SEC rather than market-moving news.
What Is Driving Attention Around EWLU?
Little of substance. At a sub-penny quote, EWLU shows negligible daily movement and no single, clearly identifiable public catalyst. Attention around micro-caps like this is usually a function of screeners flagging extreme low prices and a thin float rather than genuine company news.
Merion has not announced a development that independently explains investor interest, and any intraday swings at these price levels tend to reflect illiquidity and wide bid-ask spreads far more than fundamentals.
Key Numbers and Company Position
Verified figures for Merion are modest. Recent annual revenue has run only in the low hundreds of thousands of dollars, and the company has reported net losses, consistent with a Business operating at very small scale. Its market capitalization sits in the low thousands of dollars, while shares outstanding number in the tens of millions.
These figures should be read with caution: nano-cap OTC data can lag, and trading is sparse.
What Could Come Next?
For a company this size, meaningful catalysts would likely be corporate rather than clinical: a new financing, a reverse split, a change in control, an Acquisition or reverse merger, expanded distribution in China or the U.S., or a return to revenue growth after recent declines.
Investors monitoring EWLU may be watching for the next SEC filing, an annual or quarterly report, for evidence of whether the supplement business is stabilizing or eroding further.
Risks to Watch
The risks are significant. Sub-penny OTC stocks carry extreme volatility, minimal Liquidity and the ever-present possibility of near-total loss. Merion's small revenue base and history of losses raise questions about sustainability and potential dilution if it needs capital.
Limited public disclosure and reliance on cross-border operations add further uncertainty, and there is no analyst coverage to anchor expectations.
A Small Supplement Brand Waiting on Its Own Numbers
Merion, Inc remains a very small, thinly traded supplements company whose stock reflects the Illiquid reality of the deep OTC market rather than any confirmed catalyst. Breaking the current pattern in EWLU would likely require a tangible corporate development, fresh financing, a strategic transaction or renewed revenue momentum.
Until then, investors may be watching upcoming SEC filings for the clearest read on whether the business is stabilizing, while treating the sub-penny quote with appropriate caution.






Please wait processing your request...